Figure 11
From: Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
Survival analyses stratified by Child-Pugh grade and BCLC stage. (A) Kaplan-Meier curves of 68 HCC patients (stratum Child-Pugh A) with cortactin IHC score ranks of 0–3 and 4–6 (P <0.01); (B) Kaplan-Meier curves of 22 HCC patients (stratum Child-Pugh B) with cortactin IHC score ranks of 0–3 and 4–6 (P = 0.071); (C) Kaplan-Meier curves of 35 HCC patients (stratum BCLC 0-B) with cortactin IHC score ranks of 0–3 and 4–6 (P = 0.015); (D) Kaplan-Meier curves of 56 HCC patients (stratum BCLC C-D) with cortactin IHC score ranks of 0–3 and 4–6 (P >0.05).